• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人平衡核苷转运体1(hENT1)线粒体靶向信号的鉴定:对氟尿苷线粒体毒性种间差异的影响。

Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.

作者信息

Lee Eun-Woo, Lai Yurong, Zhang Huixia, Unadkat Jashvant D

机构信息

Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.

出版信息

J Biol Chem. 2006 Jun 16;281(24):16700-6. doi: 10.1074/jbc.M513825200. Epub 2006 Apr 4.

DOI:10.1074/jbc.M513825200
PMID:16595656
Abstract

We have previously shown that the human equilibrative nucleoside transporter 1 (hENT1) is expressed and functional in the mitochondrial membrane and that this expression enhances the mitochondrial toxicity of the nucleoside drug, fialuridine (FIAU) (Lai, Y., Tse, C. M., and Unadkat, J. D. (2004) J. Biol. Chem. 279, 4490-4497). Here we report on identification of the mitochondrial targeting sequence of hENT1. Using confocal microscopy and different truncated and point mutants of hENT1-YFP (yellow fluorescent protein) expressed in Madin-Darby canine kidney cells, we identified amino acid residues Pro(71),Glu(72), and Asn(74) (the PEXN motif) of hENT1 as important in mitochondrial targeting of hENT1. Identification of this mitochondrial targeting sequence provides a possible explanation for the dramatic difference in mitochondrial toxicity of FIAU between humans and rodents. Although the mouse ENT1 (mENT1), expressed in Madin-Darby canine kidney cells, can transport FIAU, confocal microscopy showed that mENT1-GFP (green fluorescent protein) was not localized to the mitochondria. Consistent with this observation, mitochondria isolated from mouse livers did not transport FIAU. Sequence alignment of hENT1, mENT1, and rat ENT1 (rENT1) showed that the PEXN motif of hENT1 was substituted with a PAXS motif in both mENT1 and rENT1. Substitution of PAXS in mENT1 with PEXN (to create mENT1-PEXN-GFP) and of PEXN in hENT1 with PAXS (to create hENT1-PAXS-YFP) resulted in partial mitochondrial localization of mENT1-PEXN-GFP and loss of mitochondrial localization of hENT1-PAXS-YFP. This is the first time that the mitochondrial targeting signal of hENT1 has been identified. Our data suggest that the lack of mitochondrial toxicity of FIAU in mice is due to the lack of mENT1 targeting to and expression in the mitochondria.

摘要

我们之前已经表明,人类平衡核苷转运体1(hENT1)在线粒体膜中表达且具有功能,并且这种表达增强了核苷药物氟苷(FIAU)的线粒体毒性(Lai,Y.,Tse,C.M.,以及Unadkat,J.D.(2004年)《生物化学杂志》279卷,4490 - 4497页)。在此我们报告关于hENT1线粒体靶向序列的鉴定。利用共聚焦显微镜以及在Madin - Darby犬肾细胞中表达的hENT1 - YFP(黄色荧光蛋白)的不同截短突变体和点突变体,我们鉴定出hENT1的氨基酸残基Pro(71)、Glu(72)和Asn(74)(PEXN基序)在hENT1的线粒体靶向中起重要作用。该线粒体靶向序列的鉴定为人类和啮齿动物之间FIAU线粒体毒性的显著差异提供了一种可能的解释。尽管在Madin - Darby犬肾细胞中表达的小鼠ENT1(mENT1)能够转运FIAU,但共聚焦显微镜显示mENT1 - GFP(绿色荧光蛋白)并未定位于线粒体。与该观察结果一致,从小鼠肝脏分离的线粒体不转运FIAU。hENT1、mENT1和大鼠ENT1(rENT1)的序列比对显示,hENT1的PEXN基序在mENT1和rENT1中均被PAXS基序取代。将mENT1中的PAXS替换为PEXN(以创建mENT1 - PEXN - GFP)以及将hENT1中的PEXN替换为PAXS(以创建hENT1 - PAXS - YFP)导致mENT1 - PEXN - GFP部分定位于线粒体,而hENT1 - PAXS - YFP失去线粒体定位。这是首次鉴定出hENT1的线粒体靶向信号。我们的数据表明,小鼠中FIAU缺乏线粒体毒性是由于mENT1缺乏靶向线粒体以及在线粒体中的表达。

相似文献

1
Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.人平衡核苷转运体1(hENT1)线粒体靶向信号的鉴定:对氟尿苷线粒体毒性种间差异的影响。
J Biol Chem. 2006 Jun 16;281(24):16700-6. doi: 10.1074/jbc.M513825200. Epub 2006 Apr 4.
2
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.人类平衡核苷转运体1(hENT1)的线粒体表达导致抗病毒药物的线粒体毒性增强。
J Biol Chem. 2004 Feb 6;279(6):4490-7. doi: 10.1074/jbc.M307938200. Epub 2003 Nov 7.
3
Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.人源和鼠源核苷转运蛋白对 A1 腺苷受体激动剂替卡尼松的转运:鼠源核苷同向转运蛋白 1 mENT1 可作为血脑屏障转运载体的证据。
Drug Metab Dispos. 2013 Apr;41(4):916-22. doi: 10.1124/dmd.112.049858. Epub 2013 Feb 6.
4
Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.来自小鼠脑的抑制剂敏感型(mENT1)和抑制剂抗性型(mENT2)平衡核苷转运体的分子克隆与功能特性分析
Biochem J. 2000 Dec 1;352 Pt 2(Pt 2):363-72.
5
Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies.人钠依赖性核苷转运体1(hCNT1)-青色荧光蛋白(CFP)与人平衡核苷转运体1(hENT1)-黄色荧光蛋白(YFP)在犬肾上皮细胞(Madin-Darby canine kidney cells)中的共表达。定位与向量运输研究
J Biol Chem. 2002 Oct 4;277(40):37711-7. doi: 10.1074/jbc.M204986200. Epub 2002 Jul 3.
6
Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.小鼠平衡核苷转运体1的一种新型可变剪接变体mENT1Delta11的特性分析
Mol Pharmacol. 2008 Jul;74(1):264-73. doi: 10.1124/mol.107.041871. Epub 2008 Apr 15.
7
Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.夹心培养的人肝细胞中集中性和平衡性核苷转运体的表达及肝胆转运特征
Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G570-80. doi: 10.1152/ajpgi.00542.2007. Epub 2008 Jul 17.
8
A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.平衡核苷转运蛋白基因hENT1中的单个甘氨酸突变会改变核苷转运活性以及对硝基苄硫肌苷的敏感性。
Biochemistry. 2002 Feb 5;41(5):1512-9. doi: 10.1021/bi015833w.
9
Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).人嘧啶核苷转运蛋白 1(hENT1)对核苷碱基的转运。
J Biol Chem. 2011 Sep 16;286(37):32552-62. doi: 10.1074/jbc.M111.236117. Epub 2011 Jul 27.
10
Disrupted plasma membrane localization and loss of function reveal regions of human equilibrative nucleoside transporter 1 involved in structural integrity and activity.质膜定位破坏和功能丧失揭示了人类平衡核苷转运蛋白1中参与结构完整性和活性的区域。
Biochim Biophys Acta. 2009 Oct;1788(10):2326-34. doi: 10.1016/j.bbamem.2009.08.003. Epub 2009 Aug 20.

引用本文的文献

1
A mechanistic biomarker investigation of fialuridine hepatotoxicity using the chimeric TK-NOG Hu-liver mouse model and in vitro micropatterned hepatocyte cocultures.使用嵌合型TK-NOG人肝小鼠模型和体外微图案化肝细胞共培养对非阿尿苷肝毒性进行的机制性生物标志物研究。
Toxicol Res (Camb). 2024 Jan 11;13(1):tfad120. doi: 10.1093/toxres/tfad120. eCollection 2024 Feb.
2
A systems approach reveals species differences in hepatic stress response capacity.系统方法揭示了肝脏应激反应能力的种间差异。
Toxicol Sci. 2023 Oct 30;196(1):112-125. doi: 10.1093/toxsci/kfad085.
3
Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.
探讨平衡核苷转运体在药物发现和开发中的临床重要性。
Clin Pharmacol Ther. 2023 Oct;114(4):780-794. doi: 10.1002/cpt.2984. Epub 2023 Jul 21.
4
Preclinical Pharmacokinetics and Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment.GS-441524的临床前药代动力学及性质,一种潜在的用于治疗COVID-19的口服候选药物
Front Pharmacol. 2022 Aug 16;13:918083. doi: 10.3389/fphar.2022.918083. eCollection 2022.
5
Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes ( and ).先天性核苷转运体(NT)编码基因( 和 )缺陷。
Int J Mol Sci. 2022 Aug 7;23(15):8770. doi: 10.3390/ijms23158770.
6
An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model.一种用于构建三维体外冷冻凝胶模型的基于工程蛋白的构建模块(甲基丙烯酰化白蛋白)
Gels. 2022 Jun 25;8(7):404. doi: 10.3390/gels8070404.
7
New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.新型和新兴溶质载体和三磷酸腺苷结合盒转运蛋白在药物发现和开发中的研究:国际转运蛋白联合会的展望。
Clin Pharmacol Ther. 2022 Sep;112(3):540-561. doi: 10.1002/cpt.2627. Epub 2022 May 20.
8
Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery.脑屏障转运体的药物蛋白质组学与脑靶向药物递送的底物设计
Pharm Res. 2022 Jul;39(7):1363-1392. doi: 10.1007/s11095-022-03193-2. Epub 2022 Mar 7.
9
Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases.腺苷稳态失调在脑部疾病中的新兴作用,特别关注神经退行性疾病。
J Biomed Sci. 2021 Oct 11;28(1):70. doi: 10.1186/s12929-021-00766-y.
10
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.人源肝类器官在 HBV 感染及相关肝细胞癌中的应用:患者来源的原发性模型。
Elife. 2021 Jul 30;10:e60747. doi: 10.7554/eLife.60747.